; (II) bioaccumulative properties; (III) persistence in the environment; (IV) interactions with other perfluoroalkyl or polyfluoroalkyl substances and other toxic chemicals; (V) contamination and pollution burden of impacted communities; and (VI) associated human health effects; (iii) past or possible future releases of a perfluoroalkyl or polyfluoroalkyl substance into the environment by an entity; and (iv) the use and fate of a perfluoroalkyl or polyfluoroalkyl substance used by an entity. (C) Exclusion The term user does not include an entity that neither manufactures nor uses perfluoroalkyl or polyfluoroalkyl substances, but receives perfluoroalkyl or polyfluoroalkyl substances in the normal course of operations of the entity, including a solid waste management facility, a composting facility, a public water system (as defined in section 1401 of the Safe Drinking Water Act ( 42 U.S.C. 300f )), and a publicly or privately owned or operated treatment works (as defined in section 212 of the Federal Water Pollution Control Act ( 33 U.S.C. 1292 )). I Phaseout of nonessential perfluoroalkyl and polyfluoroalkyl substances and all releases 101. Agreement with the National Academies concerning the essential uses of perfluoroalkyl or polyfluoroalkyl substances (a) Purposes The purposes of this section are to provide for the National Academies, an independent nonprofit scientific organization with appropriate expertise that is not part of the Federal Government— (1) to review and evaluate the available scientific evidence regarding categories of essential uses of perfluoroalkyl or polyfluoroalkyl substances